Xilio Therapeutics Statistics
Total Valuation
XLO has a market cap or net worth of $50.42 million. The enterprise value is -$80.91 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XLO has 5.78 million shares outstanding. The number of shares has increased by 18.53% in one year.
| Current Share Class | 5.78M |
| Shares Outstanding | 5.78M |
| Shares Change (YoY) | +18.53% |
| Shares Change (QoQ) | +22.38% |
| Owned by Insiders (%) | 9.21% |
| Owned by Institutions (%) | 22.75% |
| Float | 3.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.13 |
| Forward PS | 0.60 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.20.
| Current Ratio | 2.58 |
| Quick Ratio | 2.53 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -132.53% and return on invested capital (ROIC) is -77.21%.
| Return on Equity (ROE) | -132.53% |
| Return on Assets (ROA) | -23.24% |
| Return on Invested Capital (ROIC) | -77.21% |
| Return on Capital Employed (ROCE) | -42.66% |
| Weighted Average Cost of Capital (WACC) | 3.15% |
| Revenue Per Employee | $575,868 |
| Profits Per Employee | -$461,000 |
| Employee Count | 76 |
| Asset Turnover | 0.39 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.22% in the last 52 weeks. The beta is -0.12, so XLO's price volatility has been lower than the market average.
| Beta (5Y) | -0.12 |
| 52-Week Price Change | -14.22% |
| 50-Day Moving Average | 7.91 |
| 200-Day Moving Average | 9.54 |
| Relative Strength Index (RSI) | 58.31 |
| Average Volume (20 Days) | 39,159 |
Short Selling Information
The latest short interest is 182,492, so 3.16% of the outstanding shares have been sold short.
| Short Interest | 182,492 |
| Short Previous Month | 2.23M |
| Short % of Shares Out | 3.16% |
| Short % of Float | 5.29% |
| Short Ratio (days to cover) | 5.22 |
Income Statement
In the last 12 months, XLO had revenue of $43.77 million and -$35.04 million in losses. Loss per share was -$7.73.
| Revenue | 43.77M |
| Gross Profit | 43.77M |
| Operating Income | -41.98M |
| Pretax Income | -35.04M |
| Net Income | -35.04M |
| EBITDA | -40.44M |
| EBIT | -41.98M |
| Loss Per Share | -$7.73 |
Full Income StatementBalance Sheet
The company has $137.53 million in cash and $6.95 million in debt, with a net cash position of $130.58 million or $22.58 per share.
| Cash & Cash Equivalents | 137.53M |
| Total Debt | 6.95M |
| Net Cash | 130.58M |
| Net Cash Per Share | $22.58 |
| Equity (Book Value) | 35.27M |
| Book Value Per Share | 7.79 |
| Working Capital | 88.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.99 million and capital expenditures -$518,000, giving a free cash flow of -$5.51 million.
| Operating Cash Flow | -4.99M |
| Capital Expenditures | -518,000 |
| Depreciation & Amortization | 1.54M |
| Net Borrowing | n/a |
| Free Cash Flow | -5.51M |
| FCF Per Share | -$0.95 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -95.92% and -80.05%.
| Gross Margin | 100.00% |
| Operating Margin | -95.92% |
| Pretax Margin | -80.05% |
| Profit Margin | -80.05% |
| EBITDA Margin | -92.40% |
| EBIT Margin | -95.92% |
| FCF Margin | n/a |
Dividends & Yields
XLO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.53% |
| Shareholder Yield | -18.53% |
| Earnings Yield | -70.54% |
| FCF Yield | -11.09% |
Analyst Forecast
The average price target for XLO is $28.00, which is 221.10% higher than the current price. The consensus rating is "Buy".
| Price Target | $28.00 |
| Price Target Difference | 221.10% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | -43.30% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 16, 2026. It was a reverse split with a ratio of 1:14.
| Last Split Date | Mar 16, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:14 |
Scores
XLO has an Altman Z-Score of -3.52 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.52 |
| Piotroski F-Score | 3 |
